“arch-venture-partners” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds 06/22/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic 04/01/20 San Diego
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer 02/06/20 San Francisco
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered 02/06/20 Boston
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy 12/12/19 San Diego
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange 11/11/19 San Francisco
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test 11/07/19 Boston
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs 09/27/19 Boston
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M 09/19/19 San Diego
After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma 09/11/19 San Diego
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits 06/26/19 San Francisco
Locana, Fueled With $55M, Looks to Develop Fixes for Faulty RNA 06/21/19 San Diego
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More 05/17/19 San Diego
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks 05/07/19 Boston
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO 04/30/19 Boston
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic 04/30/19 San Diego
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases 02/28/19 San Francisco
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell 02/07/19 New York
Page 1 of 18 next page »